Trials / Completed
CompletedNCT00589355
C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.
Conditions
Timeline
- Start date
- 2002-01-01
- Primary completion
- 2003-06-01
- Completion
- 2008-10-01
- First posted
- 2008-01-09
- Last updated
- 2020-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00589355. Inclusion in this directory is not an endorsement.